In the White House’s 2016 Precision Medicine Initiative (PMI) Summit, President Obama noted that one of the challenges of the PMI is concerns regarding security. Incorporating “Big Data” into medicine to see larger treatment trends within certain populations to in turn more accurately treat patients’ individual conditions is one of the large goals of the PMI. The hope is for … Read More

One of our clinical pharmacists tells a story of his car breaking down in high school. He had it towed to a local mechanic as none of his attempts to get the car going were successful. The gas gauge was showing one quarter of a tank. After running numerous diagnostics to troubleshoot the issue, the mechanic finally determined that the … Read More

Hear what Barry Bittman, MD has to say about YouScript. A well-respected member of the medical community, Dr. Bittman is a neurologist, author, international speaker, researcher and inventor. As CEO of the Institute for Innovative Healthcare, Dr. Bittman developed a new paradigm for comprehensive integrative strategies − engaging patients and communities in the active pursuit of health and well-being.  Through … Read More

Being on the cutting-edge of precision medicine is a very exciting place to be! Everyone wants to unlock the potential and implement precision medicine initiatives. The excitement is contagious. We see the demand for this new science outpacing the research that supports it. And we constantly hear that the evidence-base is changing rapidly, but also not quickly enough. So where … Read More

Did you know the VA now covers Genelex testing for veterans? A recently approved contract is making pharmacogenetic testing accessible to clinicians in the Veterans Administration, so their patients can benefit from precision medicine immediately. Earlier this year, the U.S. Department of Veterans Affairs awarded Genelex a Federal Supply Schedule contract as a government supplier. The approval allows healthcare providers … Read More

An article published in JAMA Internal Medicine, April 2016 by Judy Jou, MA and Pamela Jo Johnson, MPH, PhD examined patterns of the use of complementary and alternative medicine (CAM), as well as rates of disclosure of CAM use to physicians. Data was collected through the 2012 National Health Interview Survey (NHIS) and CAM supplement to the Survey. Of the … Read More

The care management team is perhaps one of the largest sources of investment for ACOs or any other organization transitioning to a value-based payment model.  Therefore, it is critical that an organization use every piece of data available to guide the care team in identifying high-risk, high-cost patients to effectively manage the population as a whole. Only then does achieving … Read More

We’ve recently updated our Risk Analysis tool in YouScript to make it more useful for you! On the left side of the screen, you will see the Genetic Risk Stratification graph. This graph shows the likelihood of CYP pharmacogenetic testing being clinically actionable. It stratifies patients based on their genetic risk percentage into one of four categories: High Risk (≥40%) … Read More

What if an underutilized type of genetic testing, combined with state-of-the-art software, could cut ER visits by more than half and reduce hospitalizations by one third? Now there is a simple genetic test, that can help your doctor determine which drugs and doses are right for you.